BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6238759)

  • 1. [Use of a salbutamol-beclomethasone dipropionate combination in the treatment of chronic obstructive bronchopneumopathy].
    Greco N; Tosto L
    Clin Ter; 1984 Sep; 110(5):445-53. PubMed ID: 6238759
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of the combination of beclomethasone dipropionate and salbutamol on bronchial reactivity induced with thermal variations in chronic bronchopneumopathic patients].
    Flacco L; Colozzi A; Tamburro P; Casale E
    Arch Monaldi; 1979; 34(1-2):20-8. PubMed ID: 554571
    [No Abstract]   [Full Text] [Related]  

  • 3. Salbutamol plus beclomethasone dipropionate (Ventolin Flogo) vs. fenoterol (Dosberotec) in chronic obstructive lung disease therapeutic strategy: a 4-week clinical trial.
    Perri G; Giovannini M; Spada E
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):274-8. PubMed ID: 3891642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of inhaled salbutamol with a combination of salbutamol and beclomethasone dipropionate in moderately severe asthma.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 1994; 36(3):119-24. PubMed ID: 7737699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beclomethasone spray in the therapy of re-acutized chronic obstructive bronchopneumopathy].
    Catenazzo G; Conti F; Galanti B
    Clin Ter; 1975 May; 73(3):245-50. PubMed ID: 1126141
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic action of salbutamol as compared with orciprenaline in patients with chronic obstructive bronchopneumopathy. Double-blind study].
    Vesco R; Sussi GW
    Minerva Med; 1976 Apr; 67(17):1155-9. PubMed ID: 772479
    [No Abstract]   [Full Text] [Related]  

  • 7. Compliance with aerosol therapy in chronic obstructive lung disease.
    Chryssidis E; Frewin DB; Frith PA; Dawes ER
    N Z Med J; 1981 Nov; 94(696):375-7. PubMed ID: 6948205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
    Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
    Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beclomethasone dipropionate aerosol in the treatment of obstructive lung (author's transl)].
    Popovac D; Haxhiu MA; Davila D
    Plucne Bolesti Tuberk; 1980; 32(3):128-31. PubMed ID: 7465685
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiopathological evaluation of the combined beclomethasone-salbutamol therapy].
    Carnimeo N; Resta O; Valerio G; Foschino MP
    Arch Monaldi; 1979; 34(1-2):49-54. PubMed ID: 554574
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiparametrical approach to fog-challenge-induced bronchial hyperreactivity in asthmatics--protective effects of salbutamol plus beclomethasone dipropionate.
    Pomari C; Turco P; Trevisan F; Zoccatelli D; Dal Negro RW
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):515-8. PubMed ID: 6500772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled beclomethasone dipropionate administered through a new spacer device: a controlled clinical study.
    Vecchiet L; Pieralisi G; Ambrosi L; Di Lorenzo L; Cantini L
    Adv Ther; 1996; 13(6):335-46. PubMed ID: 10165114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoscopic biopsies of bronchial mucosa before and after beclomethasone dipropionate therapy.
    Thiringer G; Eriksson N; Malmberg R; Svedmyr N; Zettergren L
    Postgrad Med J; 1975; 51 Suppl 4():30-1. PubMed ID: 1105514
    [No Abstract]   [Full Text] [Related]  

  • 14. [Respiratory function studies in patients with bronchopneumopathy treated with salbutamol].
    Spina G; Bonsignore C
    Minerva Med; 1976 Mar; 67(15):995-7. PubMed ID: 1264372
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nocturnal asthma: inhalation treatment with high doses of salbutamol and beclomethasone].
    Rodríguez Sanchón B; Manresa F; Romero P; Cardona MJ
    Rev Clin Esp; 1986 Apr; 178(7):322-6. PubMed ID: 3738002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Becotide rotadisks 0.1 mg/0.2 mg/0.4 mg and sultanol rotadisks 0.2 mg/0.4 mg, powder for dry inhalation with the Diskhaler].
    Nanz S
    Wien Klin Wochenschr; 1993; 105(11):330-3. PubMed ID: 8333201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
    Magnussen H; Willenbrock U; Jörres R
    Med Klin (Munich); 1995 Apr; 90(4):214-9. PubMed ID: 7776933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beclomethasone dipropionate in bronchial obstructive syndromes].
    Miti L; Sanguinetti CM
    Minerva Med; 1978 Mar; 69(13):867-72. PubMed ID: 643228
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of inhaled corticosteroids in the management of non asthmatic chronic airflow obstruction.
    Boothman-Burrell D; Delany SG; Flannery EM; Hancox RJ; Taylor DR
    N Z Med J; 1997 Oct; 110(1053):370-3. PubMed ID: 9364183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis.
    Carlsen KH; Leegaard J; Larsen S; Orstavik I
    Arch Dis Child; 1988 Dec; 63(12):1428-33. PubMed ID: 3069051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.